News

Publication of Glioblastoma Human Retrospective and Prospective Clinical Data

Events

Coming soon.

Sept. 28, 2020. Data from glioblastoma studies with RecurX Bio technology was published today in Nature Biomedical Engineering.

Konstantopoulos Lab Receives Maryland Translational Grant

Sept. 14, 2020.We are pleased to announce that Dr. Konstantopoulos, the scientific founder of RecurX Bio, and his co-collaborator, Dr. Stuart Martin at the University of Maryland, have received a Maryland translational grant, the first phase in a series of grants that the company will be eligible for through the state of Maryland. Work under this grant will include animal studies and retrospective clinical trials in breast cancer.

Announcing AIM HI Women's Venture Competition Semi-Finalists

Aug. 11, 2020. We are pleased to announce that RecurX Bio has been chosen one of eight semi-finalists for the AIM HI Women’s Venture competition. Read more.

© 2020 by RecurX Bio, Inc. All Rights Reserved in all countries. RecurX Bio is a trademark of RecurX Bio, Inc.